Safety and efficacy of camrelizumab combined with radiotherapy as neoadjuvant therapy for locally advanced esophageal squamous cell carcinoma: a prospective single-arm phase II clinical trial protocol

DiscussionWe designed this prospective single-arm phase II clinical study to evaluate the combination of camrelizumab and standard radiotherapy as preoperative neoadjuvant therapy for patients with resectable ESCC as part of the quest for better treatment options for patients with locally advanced ESCC.Trial registrationThis trial protocol has been registered on the NIH Clinical Trials database (www.clinicaltrials.gov/, NCT05176002.  Registered on 2022/01/04). The posted information will be updated as needed to reflect protocol amendments and study progress.
Source: Trials - Category: Research Source Type: clinical trials